Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies

Andrew J. Wiele, Tharakeswara K. Bathala, Andrew W. Hahn, Lianchun Xiao, Munevver Duran, Jeremy A. Ross, Eric Jonasch, Amishi Y. Shah, Matthew T. Campbell, Pavlos Msaouel, Nizar M. Tannir

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies'. Together they form a unique fingerprint.

Medicine & Life Sciences